Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Compassionate Use of Kv7.2/7.3 Potassium Channel Activator Opakalim (BHV-7000) in a Child with KCNQ2 Developmental and Epileptic Encephalopathy

Author:Olson, Heather   Maguire-Lobos, Eorna   Mansour, Kathryn   Correa, Grace   Lerner, Jason   Bozik, Michael   Dworetzky, Steven   Sevinsky, Heather   Sweeney, Kelly   Potashman, Michele   Paul, Prokash   Kendrick, Racheal   Donatelli, Stephanie   Patel, Archana   Wiltrout, Kimberly   Achkar, Christelle   Poduri, Annapurna   

Session Name:P10: Epilepsy/Clinical Neurophysiology (EEG): Clinical Epilepsy Reports and Studies  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P10.002  

Author Institution:Boston Children's Hospital, Peabody, MA  Boston Children's Hospital, MA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Pittsburgh, PA  Biohaven Pharmaceuticals, CT  Certara, PA  Certara, Princeton, NJ  Boston Children's Hospital, Boston, MA  

A New Diagnostic Biomarker in the Study of Amyotrophic Lateral Sclerosis

Author:Rosenfeld, Jeffrey   Lingappa, Vishwanath   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.002  

Author Institution:Loma Linda University School Medicine - NEUROLOGY, Loma Linda University, CA  Prosetta Bioscience, San Francisco, CA  

Characterizing Stimulation Artifacts in Deep Brain Stimulation Recordings Across Neurological Disorders

Author:Narendranath, Poorvi   De Hemptinne, Coralie   Cagle, Jackson   Wong, Joshua   

Session Name:P10: Movement Disorders: Neuromodulation 2  

Topic:Movement Disorders  

Program Number:P10.002  

Author Institution:University of Florida College of Medicine - Neurology, Gainesville, FL  University of Florida College of Medicine - Neurology, Gainesville,, FL  

Multiple Sclerosis-associated Cardiovascular Disease–Related Mortality: A Retrospective Cohort Study Using Real-world Data from the USA, 1999–2023

Author:Hemida Saleh, Mohamed   Ibrahim, Alyaa Ahmed   Hussein, Mirna   Tablawy, Mahmoud   Saghir, Maryam   Zeeshan, Nafila   Hamza, Ahmed   Khalid, Maliha   Saghir, Eshal   Rabie, Omar   Qaisi, Waheed   Alagamy, Mostafa   Sarfraz, Muhammad Raza   Ali, Amro   

Session Name:P10: Multiple Sclerosis: Adverse Events  

Topic:Multiple Sclerosis  

Program Number:P10.002  

Author Institution:Alexandria Faculty of Medicine, Alexandria, Egypt, Alexandria, Egypt  Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Cairo, Egypt  Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan, Karachi, Pakistan  Dow Medical College, Karachi, Pakistan, Karachi, Pakistan  Department of Neuroscience, University of Pittsburgh, Pennsylvania, USA, Pittsburgh, PA  Jinnah Sindh Medical University, Karachi, Pakistan, Karachi, Pakistan  Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan, Karachi, Pakistan  Faculty of Medicine, Helwan University, Cairo, Egypt , Cairo, Egypt  An-Najah National University, Department of Medicine, Nablus, Palestine  Kasr Alainy Faculty of Medicine - Cairo University,Cairo, Egypt, Cairo, Egypt  Allied Hospital, Faisalabad Medical University, Faisalabad, Pakistan, Faisalabad, Pakistan  Department of Medicine, Community Regional Medical Center, Fresno, California, USA, Fresno, CA  

Janus Kinase Inhibitor Therapy in Patients With Multiple Sclerosis and Co-morbid Conditions

Author:Pua, Danielle Kei   Madill, Evan   Bhattacharyya, Shamik   

Session Name:P10: Multiple Sclerosis: Clinical Science 2  

Topic:Multiple Sclerosis  

Program Number:P10.002  

Author Institution:Westchester Medical Center, Valhalla, NY  University of Washington, Seattle, WA  Brigham and Women'S Hospital, Boston, MA